• Indian Immunologicals Ltd (IIL), a wholly-owned subsidiary of National Dairy Development Board (NDDB) has launched India’s ‘first’ indigenously developed Hepatitis A vaccine, Havisure.
  • The vaccine, launched after eight years of dedicated work, underwent comprehensive studies, including pre-clinical toxicology studies in animals, phase I trials in human subjects, and phase 2/3 trials involving nearly 500 healthy volunteers across different age groups.
  • Manufactured at IIL’s Gachibowli plant in Hyderabad, the focus initially is on the domestic market with a plan to produce 1 million doses annually, contributing to the country's self-sufficiency.
  • The company aims for WHO pre-qualification for 'Havisure,' providing access to ....
Do You Want to Read More?
Subscribe Now

To get access to detailed content

Already a Member? Login here

Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.